Inhibition of protein kinase C delta attenuates blood-retinal barrier breakdown in diabetic retinopathy.
about
Microvascular complications and diabetic retinopathy: recent advances and future implicationsPathophysiology of diabetic retinopathyProtein kinase C activation modulates reversible increase in cortical blood-brain barrier permeability and tight junction protein expression during hypoxia and posthypoxic reoxygenation.Protective effects of astragaloside IV on db/db mice with diabetic retinopathyRas-related C3 botulinum toxin substrate 1 activation is involved in the pathogenesis of diabetic retinopathy.Histone hyperacetylation up-regulates protein kinase Cδ in dopaminergic neurons to induce cell death: relevance to epigenetic mechanisms of neurodegeneration in Parkinson diseasePigment epithelium-derived factor protects the morphological structure of retinal Müller cells in diabetic ratsDiabetes and retinal vascular dysfunction.Simultaneous application of bevacizumab and anti-CTGF antibody effectively suppresses proangiogenic and profibrotic factors in human RPE cellsInterleukin-1β-induced barrier dysfunction is signaled through PKC-θ in human brain microvascular endothelium.Beta-adrenergic receptor agonist decreases VEGF levels through altered eNOS and PKC signaling in diabetic retina.Animal models of diabetic retinopathy: doors to investigate pathogenesis and potential therapeuticsMyosin light chain kinase signaling in endothelial barrier dysfunction.Effects of high glucose-induced Cx43 downregulation on occludin and ZO-1 expression and tight junction barrier function in retinal endothelial cells.Original Research: Potential ocular protection and dynamic observation of Polygonatum sibiricum polysaccharide against streptozocin-induced diabetic rats' model.Vascular endothelial tight junctions and barrier function are disrupted by 15(S)-hydroxyeicosatetraenoic acid partly via protein kinase C ε-mediated zona occludens-1 phosphorylation at threonine 770/772.Inhibition of Stat3 by a Small Molecule Inhibitor Slows Vision Loss in a Rat Model of Diabetic Retinopathy.Microvascular modifications in diabetic retinopathy.Regulation of paracellular permeability: factors and mechanisms.Protein kinase C and toll-like receptor signaling.Hyperglycaemia promotes cerebral barrier dysfunction through activation of protein kinase C-β.A compartmentalized microfluidic chip with crisscross microgrooves and electrophysiological electrodes for modeling the blood-retinal barrier.miR-15a/16 inhibits TGF-beta3/VEGF signaling and increases retinal endothelial cell barrier proteins.AMA0428, A Potent Rock Inhibitor, Attenuates Early and Late Experimental Diabetic Retinopathy.Calcium Dobesilate Prevents Neurodegeneration and Vascular Leakage in Experimental Diabetes.Specific role of tight junction proteins claudin-5, occludin, and ZO-1 of the blood-brain barrier in a focal cerebral ischemic insult.Investigation of barrier characteristics in the hyaloid-retinal vessel of zebrafish.Scutellarin inhibits translocation of protein kinase C in diabetic thoracic aorta of the rat.
P2860
Q26822476-40BE1404-548F-40DA-B168-19F2240E5F0EQ26865897-9F57362D-3745-42FC-9B63-EFB3B138E016Q34504992-DA2E0F2E-B125-4CC4-A79D-1E6F326BD6B0Q34549870-2EBF4C66-A07B-4CCA-8BFD-F7FA25351CCCQ34585364-9D244396-DB83-439F-9D6D-DF2204480BCBQ34683308-93F7EA65-87EE-4C58-9B4F-7A6AB2B0368BQ34735773-642CC72D-AACC-48DC-AF66-D18D02EBB477Q35017752-75E6464F-D43A-4A18-BCF9-211C6162C693Q35359339-7C5909EF-6046-426E-9CF0-B9BFFDAD01C8Q35993746-0F7F735F-B902-40C4-8E51-8AB59229D0BFQ36687280-79D713E6-3A74-4381-A0C2-E8E49B9EFCE6Q36959934-D93A5BB8-6386-4883-BDB8-D90FDD2DCBC0Q37076073-AE3DBCF6-EBE1-43EE-8F9A-237808D7F5BAQ37214892-A3565624-F475-4C83-A83D-FD766F61B8DDQ37551116-80C9DA8F-C987-4D01-BB5B-BE51971F8F13Q37563388-4F761619-AA1F-41A9-8B36-FF391BAFBB9FQ37744827-CE821CB9-7E06-48A6-B182-698D94EF7BCAQ37879581-2B2395B4-9AEF-4D32-9815-9D2D8A561832Q38141920-BB020430-232F-4467-B143-63FBC7FC6663Q38266586-50D5AB3D-C1E2-4F8F-8F57-DEC07016D41FQ43407851-F0AB38A2-4003-4A1E-A728-5760A896D531Q47320701-41AE2BAC-668F-4264-9138-5FEB58E1A77AQ47993537-FFB3E519-CD40-4293-9A42-4F80B6D6DE99Q49037118-D6F5A0F0-1B9C-4A46-A11C-BD971B6A365AQ50205839-9BB64DE9-297D-43D4-9A63-A42EB668E179Q50282885-283D7401-912D-4929-8AFE-D7B04C2168F5Q50524854-8DFA967F-E5EB-410F-A0E9-BA086D3C57DDQ53205342-C0C2A84C-4FE1-4362-BBB3-433B6F61B9B1
P2860
Inhibition of protein kinase C delta attenuates blood-retinal barrier breakdown in diabetic retinopathy.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Inhibition of protein kinase C ...... kdown in diabetic retinopathy.
@ast
Inhibition of protein kinase C ...... kdown in diabetic retinopathy.
@en
type
label
Inhibition of protein kinase C ...... kdown in diabetic retinopathy.
@ast
Inhibition of protein kinase C ...... kdown in diabetic retinopathy.
@en
prefLabel
Inhibition of protein kinase C ...... kdown in diabetic retinopathy.
@ast
Inhibition of protein kinase C ...... kdown in diabetic retinopathy.
@en
P2093
P2860
P1476
Inhibition of protein kinase C ...... kdown in diabetic retinopathy.
@en
P2093
Hyoung-Oh Jun
Jeong-Hun Kim
Jin Hyoung Kim
Kyu-Won Kim
Young Suk Yu
P2860
P304
P356
10.2353/AJPATH.2010.090398
P407
P577
2010-01-28T00:00:00Z